DSS-treated Nckx3-deficient mice showed severe DSS colitis, which can be determined by several clinicopathological indicators, including more severe weight loss, diarrhea, hematochezia, shortening of the colon length, histological lesions, and increased proinflammatory cytokines. The gene discussed is SLC24A3; the disease is colitis.